Broadwood Capital Inc Oncocyte Corp Transaction History

Broadwood Capital Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.2 - $0.35 $5.37 Million - $9.39 Million	26,827,638 Added 114.88%	50,181,335 $11.5 Million
Q2 2022 Aug 15, 2022	BUY	$0.86 - $1.53 $5.16 Million - $9.19 Million	6,003,752 Added 34.6%	23,353,697 $21 Million
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $2.02 Million - $3.38 Million	573,461 Added 3.42%	17,349,945 $61.8 Million
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $4.92 Million - $13.4 Million	2,060,280 Added 14.0%	16,776,484 $87.1 Million
Q2 2020 Aug 14, 2020	BUY	$1.91 - $3.45 $2.01 Million - $3.62 Million	1,050,000 Added 7.68%	14,716,204 $28.1 Million
Q1 2020 May 15, 2020	BUY	$1.76 - $3.02 $2.45 Million - $4.2 Million	1,391,466 Added 11.34%	13,666,204 $33.5 Million
Q4 2019 Feb 14, 2020	BUY	$1.51 - $2.27 $1.78 Million - $2.67 Million	1,176,471 Added 10.6%	12,274,738 $27.6 Million
Q3 2019 Nov 14, 2019	BUY	$1.59 - $2.51 $4.77 Million - $7.53 Million	3,000,000 Added 37.04%	11,098,267 $23.3 Million
Q1 2019 May 15, 2019	BUY	$1.47 - $5.91 $783,999 - $3.15 Million	533,333 Added 7.05%	8,098,267 $32 Million
Q1 2018 May 15, 2018	BUY	$1.25 - $4.6 $4.96 Million - $18.3 Million	3,968,254 Added 110.33%	7,564,934 $15.9 Million
Q3 2017 Nov 14, 2017	BUY	$4.55 - $7.55 $16.4 Million - $27.2 Million	3,596,680	3,596,680 $27.2 Million

1.5M

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $342M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Broadwood Capital Inc, based on Form 13F filings with the SEC.

Stay updated on Broadwood Capital Inc with notifications on news.